First Returns on Spravato - Success!
- LouCouPsych
- Sep 25, 2019
- 1 min read
Since launching Spravato (intranasal esketamine) treatment at LouCouPsych, there has been genuine excitement and buzz, with great interest in the outcomes. As of this writing, we have 3 patients who have agreed to give feedback and allow publication of their responses to some questions. Dr. Mirza and staff have noticed a tremendous return on investment, with mood and function significantly improving, often quite rapidly. Below is a live and continuously updating graph showing individual responses to treatment over time in weeks against their PHQ-9 scores, a way to objectively quantify depression.
As can be seen, individuals were scoring in the "Moderately-severe" to "Severely" depressed range were down to "Minimal-to-none" within weeks. That is a game changer.
Regarding the experience as a whole, here is a bit more detailed report.
To start your journey with Spravato (intranasal esketamine) for treatment resistant depression, or to learn more, please contact us today!
I found matlab assignment help useful while practicing MATLAB problems, especially for understanding logic errors and improving my coding approach.
It's important to monitor your mental health just like your physical health. Using the PHQ-9 online periodically is a great way to track your mood over time.